Pubblicazioni

Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?

2021 - ACTA RADIOLOGICA

Marzocca, F.; Moffa, G.; Landi, V. N.; Panzironi, G.; Kirchin, M. A.; Pediconi, F.; Galati, F.

MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis

2019 - NEURORADIOLOGY

Cocozza, Sirio; Pontillo, Giuseppe; Lanzillo, Roberta; Russo, Camilla; Petracca, Maria; Di Stasi, Martina; Paolella, Chiara; Vola, Elena Augusta; Criscuolo, Chiara; Moccia, Marcello; Lamberti, Anna; Monti, Serena; Brescia Morra, Vincenzo; Elefante, Andrea; Palma, Giuseppe; Tedeschi, Enrico; Brunetti, Arturo

Reply to Radbruch et al.: "interpreting signal-intensity ratios without visible T1 hyperintensities in clinical gadolinium retention studies"

2017 - PEDIATRIC RADIOLOGY

Rossi Espagnet, Maria Camilla; TomÃ , Paolo; Napolitano, Antonio

Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis

2015 - CIRCULATION

Fontana, Marianna; Pica, Silvia; Reant, Patricia; Abdel Gadir, Amna; Treibel, Thomas A.; Banypersad, Sanjay M.; Maestrini, Viviana; Barcella, William; Rosmini, Stefania; Bulluck, Heerajnarain; Sayed, Rabya H.; Patel, Ketna; Mamhood, Shameem; Bucciarelli Ducci, Chiara; Whelan, Carol J.; Herrey, Anna S.; Lachmann, Helen J.; Wechalekar, Ashutosh D.; Manisty, Charlotte H.; Schelbert, Eric B.; Kellman, Peter; Gillmore, Julian D.; Hawkins, Philip N.; Moon, James C.